{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:53:49Z","timestamp":1788324829846,"version":"build-2803163510"},"reference-count":29,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>A growing number of systemic hereditary inflammatory diseases characterized by periodic fevers and elevated acute-phase proteins during flares has been linked to deregulated inflammasome function and excessive bioactivity of interleukin (IL)-1. All these conditions respond, at varying degrees, to the specific blockade of IL-1. The remarkable progress with IL-1 antagonists in treating hereditary inflammasome-based disorders has offered new hope for several patients with further non-hereditary autoinflammatory conditions from multifactorial backgrounds. The effectiveness of the IL-1 blockade has transformed our understanding and management of many complex diseases and highlighted the role of aberrant IL-1 signaling in enigmatic conditions, characterized by recurrent or continuous inflammation and a lack of a role for autoreactive T-cells or autoantibody production. To date, the long-term blockade of IL-1 has been found to restore the clinical equilibrium in systemic inflammasomopathies of childhood, and IL-1 inhibitors have become cardinal weapons in managing both monogenic innate immunity defects and a plethora of polygenic diseases occurring in children, including Still\u2019s disease, Kawasaki disease, recurrent pericarditis, chronic non-bacterial osteomyelitis, and Beh\u00e7et\u2019s disease. Very few side effects have been reported with the long-term use of anakinra, rilonacept, or canakinumab, and their safety profile has been largely documented even in childhood. Further investigations into the role of inflammasomes in the pathogenesis of autoimmune conditions as well as brain degenerative or cardiovascular disorders can be expected, paving the way for precision medicine with benefits beyond inhibiting signaling by individual IL-1-family cytokines.<\/jats:p>","DOI":"10.3390\/ijms26051872","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:08:50Z","timestamp":1740136130000},"page":"1872","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Golden Card of Interleukin-1 Blockers in Systemic Inflammasomopathies of Childhood"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7032-7779","authenticated-orcid":false,"given":"Donato","family":"Rigante","sequence":"first","affiliation":[{"name":"Department of Life Sciences and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy"},{"name":"Periodic Fever and Rare Diseases Research Centre, Universit\u00e0 Cattolica Sacro Cuore, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1126\/science.ado2152","article-title":"The Holobiont Biology Network. The disciplinary matrix of holobiont biology","volume":"386","author":"Bordenstein","year":"2024","journal-title":"Science"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"10801","DOI":"10.1038\/s41467-024-55083-3","article-title":"Cytokine-armed pyroptosis induces antitumor immunity against diverse types of tumors","volume":"15","author":"Orehek","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/imr.12606","article-title":"The family of interleukin-1 receptors","volume":"281","author":"Boraschi","year":"2018","journal-title":"Immunol. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41590-024-01777-1","article-title":"International nomenclature guidelines for the IL-1 family of cytokines and receptors","volume":"25","author":"Gaballa","year":"2024","journal-title":"Nat. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4078\/jrd.2024.0095","article-title":"Associations between circulating interleukin-18 levels and adult-onset Still\u2019s disease: A meta-analysis","volume":"32","author":"Lee","year":"2025","journal-title":"J. Rheum. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.autrev.2018.01.020","article-title":"NLRP3: A promising therapeutic target for autoimmune diseases","volume":"17","author":"Shen","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/jebm.12406","article-title":"Phenotype variability of autoinflammatory disorders in the pediatric patient: A pictorial overview","volume":"13","author":"Rigante","year":"2020","journal-title":"J. Evid. Based Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/07853890.2010.547212","article-title":"Autoinflammatory diseases and cardiovascular manifestations","volume":"43","author":"Rigante","year":"2011","journal-title":"Ann. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00403-011-1134-z","article-title":"Monogenic autoinflammatory syndromes at a dermatological level","volume":"303","author":"Rigante","year":"2011","journal-title":"Arch. Dermatol. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1177\/039463201102400402","article-title":"Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes","volume":"24","author":"Cantarini","year":"2011","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/03009740310003974","article-title":"Etanercept induces improvement of arthropathy in chronic infantile neurological cutaneous articular (CINCA) syndrome","volume":"32","author":"Federico","year":"2003","journal-title":"Scand. J. Rheumatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00381-006-1280-3","article-title":"Hydrocephalus in CINCA syndrome treated with anakinra","volume":"22","author":"Rigante","year":"2006","journal-title":"Childs Nerv. Syst."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Shu, Z., Zhang, Y., Han, T., Li, Y., Piao, Y., Sun, F., Ma, J., Mo, W., Sun, J., and Chan, K.W. (2023). The genetic and clinical characteristics and effects of canakinumab on cryopyrin-associated periodic syndrome: A large pediatric cohort study from China. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1267933"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Sangiorgi, E., and Rigante, D. (2022). The clinical chameleon of autoinflammatory diseases in children. Cells, 11.","DOI":"10.3390\/cells11142231"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/rheumatology\/kex373","article-title":"Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the pyrin inflammasome","volume":"57","author":"Jamilloux","year":"2018","journal-title":"Rheumatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1177\/039463201002300303","article-title":"Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: Personal experience and review of the literature","volume":"23","author":"Cantarini","year":"2010","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/intimm\/dxz024","article-title":"TNF receptor signalling in autoinflammatory diseases","volume":"31","author":"Holbrook","year":"2019","journal-title":"Int. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Jeyaratnam, J., and Frenkel, J. (2020). Management of mevalonate kinase deficiency: A pediatric perspective. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01150"},{"key":"ref_20","first-page":"1","article-title":"The protean visage of systemic autoinflammatory syndromes: A challenge for inter-professional collaboration","volume":"14","author":"Rigante","year":"2010","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_21","first-page":"RA179","article-title":"Autoinflammatory syndromes behind the scenes of recurrent fevers in children","volume":"15","author":"Rigante","year":"2009","journal-title":"Med. Sci. Monit."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41587-021-01170-5","article-title":"The characteristics of patents impacting availability of biosimilars","volume":"40","author":"Beall","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"ref_23","first-page":"93","article-title":"Interleukin-1: Ariadne\u2019s thread in autoinflammatory and autoimmune disorders","volume":"17","author":"Cantarini","year":"2015","journal-title":"Isr. Med. Assoc. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/ard-2024-225854","article-title":"Efficacy and safety of therapies for Still\u2019s disease and macrophage activation syndrome (MAS): A systematic review informing the EULAR\/PReS guidelines for the management of Still\u2019s disease","volume":"83","author":"Bindoli","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"ref_25","first-page":"301","article-title":"Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications","volume":"11","author":"Pardeo","year":"2007","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00296-009-1337-1","article-title":"Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome","volume":"30","author":"Rigante","year":"2010","journal-title":"Rheumatol. Int."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Dourdouna, M.M., Tatsi, E.B., Syriopoulou, V., and Michos, A. (2024). Proteomic signatures of multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19: A narrative review. Children, 11.","DOI":"10.3390\/children11101174"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00281-015-0498-0","article-title":"Advances in the genetically complex autoinflammatory diseases","volume":"37","author":"Ombrello","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1093\/rheumatology\/keab419","article-title":"Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: Observational study from the International AIDA Registry","volume":"60","author":"Sota","year":"2021","journal-title":"Rheumatology"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/5\/1872\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:40:12Z","timestamp":1760028012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/5\/1872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["ijms26051872"],"URL":"https:\/\/doi.org\/10.3390\/ijms26051872","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]}}}